151 related articles for article (PubMed ID: 30895362)
1. Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy.
Gires B; Khene ZE; Bigot P; Alimi Q; Peyronnet B; Verhoest G; Manunta A; Bensalah K; Mathieu R
World J Urol; 2019 Dec; 37(12):2727-2736. PubMed ID: 30895362
[TBL] [Abstract][Full Text] [Related]
2. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
3. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
[TBL] [Abstract][Full Text] [Related]
4. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
[TBL] [Abstract][Full Text] [Related]
6. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
[TBL] [Abstract][Full Text] [Related]
7. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
8. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of pathologic nodal positivity in non-metastatic patients with renal cell carcinoma who underwent radical or partial nephrectomy.
Kim SH; Park B; Hwang EC; Hong SH; Jeong CW; Kwak C; Byun SS; Chung J
Sci Rep; 2021 Feb; 11(1):3079. PubMed ID: 33542395
[TBL] [Abstract][Full Text] [Related]
10. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
[TBL] [Abstract][Full Text] [Related]
11. Imaging strategy and outcome following partial nephrectomy.
Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
[TBL] [Abstract][Full Text] [Related]
12. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma.
Yang L; Wu Q; Xu L; Zhang W; Zhu Y; Liu H; Xu J; Gu J
BMC Cancer; 2015 Feb; 15():67. PubMed ID: 25886010
[TBL] [Abstract][Full Text] [Related]
14. Low yield of surveillance imaging after surgery for T1 kidney cancer.
Feuerstein MA; Musser JE; Kent M; Chevinsky M; Cha EK; Kimm S; Hilton WM; Sjoberg DD; Donahue TF; Vargas HA; Coleman JA; Russo P
World J Urol; 2016 Jul; 34(7):949-53. PubMed ID: 26511748
[TBL] [Abstract][Full Text] [Related]
15. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
17. Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.
Kroeger N; Lebacle C; Hein J; Rao PN; Nejati R; Wei S; Burchardt M; Drakaki A; Strother M; Kutikov A; Uzzo R; Pantuck AJ
Eur J Cancer; 2022 Jun; 168():68-76. PubMed ID: 35461012
[TBL] [Abstract][Full Text] [Related]
18. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.
Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J
Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266
[TBL] [Abstract][Full Text] [Related]
19. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.
Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J
Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921
[TBL] [Abstract][Full Text] [Related]
20. Abbreviated CT protocol for postoperative surveillance of renal cancer.
Gofrit ON; Rabinovich I; Yutkin V; Pode D; Duvdevani M; Landau EH; Hidas G; Goldberg SN
Urol Oncol; 2018 Nov; 36(11):498.e9-498.e13. PubMed ID: 30228095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
